AgingResearch.News

PhenoAge

Biomarker8 papers9 findings

Human cohorts link PhenoAge to gout risk, dementia, mortality, cognitive function, C-reactive protein, body mass index, and telomere length. In a human trial in participants with prediabetes, a lifestyle modification programme decreased PhenoAge.

  • Human trial1
  • Humans7

Interventions

1

Lifestyle modification program

downin humans1

1 study
  1. Lifestyle modification program decreases PhenoAge in humans (-4.9 vs. +1.3 years).

    “participants in the lifestyle modification program (LMP) showed a significant reduction in PhenoAge (-4.9 vs. +1.3 years; between-group p”

    Human trialprediabetes6 monthsn = 181

    Lifestyle modification reduces phenotypic age in adults with prediabetes · Frontiers in aging · 10 Sep 2026

Lifestyle modification program →

Effects

1

Dementia

mediatesin humans1HR 1.0062

1 study
  1. PhenoAge mediates dementia in humans (HR 1.0062, 95% CI 1.0002-1.0125).

    Humanscombined with KDM-BA for childhood/adolescence smoking association13.67 yearsn = 285,009

    Accelerated biological aging in the association between early-life tobacco smoke exposure and dementia risk: An exploratory mediation analysis · Journal of Alzheimer's disease : JAD · 29 Sep 2026

Dementia →

Associations

6

Gout

upin humans1HR 1.69

1 study
  1. PhenoAge predicts gout in humans (HR 1.69, 95% CI 1.60-1.78).

    Humansin UKB cohort; incident gout

    Accelerated biological aging links to higher gout risk and increased mortality · Maturitas · 25 Sep 2026

  2. PhenoAge is associated with gout in humans (OR 1.04, 95% CI 1.03-1.05).

    Humansin NHANES; per 1-year increase in advance

    Accelerated biological aging links to higher gout risk and increased mortality · Maturitas · 25 Sep 2026

Gout →

Mortality

upin humans1HR 1.45

1 study
  1. PhenoAge predicts mortality in humans (HR 1.45 (1.40 1.50)).

    Humanson NHANES IV holdoutn = 24,650

    Mechanistic biological age clock matches PhenoAge in predicting human mortality · bioRxiv · 30 Sep 2026 · Preprint

Cognitive function

downin humans1

1 study
  1. Cognitive function is associated with PhenoAge in humans (-9.72 ± 8.37 vs 0.00 ± 4.56 years; Cohen's d = -1.44).

    Humansin Healthy Cognitive Agers aged ≥80 years maintaining MMSE = 30n = 80

    Older adults with preserved cognition show slower biological aging and longer telomeres · Aging and disease · 23 Sep 2026

DNAmTL

downin humans1

1 study
  1. DNAmTL is associated with PhenoAge in humans.

    “DNAmTL was inversely associated with both domains and did not differ significantly across domains.”

    Humansboth mitotic and early-life systemic dysregulation domainsblood

    Blood methylation clocks capture two distinct biological domains of aging · Genes · 9 Sep 2026

DNAmTL →

BMI

upin humans1

1 study
  1. BMI is associated with PhenoAge in humans.

    “Cross-domain tests confirmed significantly stronger associations for the early-life systemic dysregulation domain for CRP, BMI, and alcohol methylation”

    Humansearly-life systemic dysregulation domainblood

    Blood methylation clocks capture two distinct biological domains of aging · Genes · 9 Sep 2026

BMI →

C-reactive protein

upin humans1

1 study
  1. C-reactive protein is associated with PhenoAge in humans.

    “CRP, BMI, alcohol methylation, and AHRR/cg05575921 were positively associated with the early-life systemic dysregulation domain”

    Humansearly-life systemic dysregulation domainblood

    Blood methylation clocks capture two distinct biological domains of aging · Genes · 9 Sep 2026

C-reactive protein →

Latest

Nov 2025: 0Dec 2025: 0Jan 2026: 0Feb 2026: 0Mar 2026: 0Apr 2026: 0May 2026: 0Jun 2026: 0Jul 2026: 0Aug 2026: 0Sep 2026: 8Oct 2026: 08